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Abstract
Fluorescent tagging of viral particles by genetic means enables the study of virus dynamics in living cells. However, the
study of beta-herpesvirus entry and morphogenesis by this method is currently limited. This is due to the lack of replication
competent, capsid-tagged fluorescent viruses. Here, we report on viable recombinant MCMVs carrying ectopic insertions of
the small capsid protein (SCP) fused to fluorescent proteins (FPs). The FPs were inserted into an internal position which
allowed the production of viable, fluorescently labeled cytomegaloviruses, which replicated with wild type kinetics in cell
culture. Fluorescent particles were readily detectable by several methods. Moreover, in a spread assay, labeled capsids
accumulated around the nucleus of the newly infected cells without any detectable viral gene expression suggesting
normal entry and particle trafficking. These recombinants were used to record particle dynamics by live-cell microscopy
during MCMV egress with high spatial as well as temporal resolution. From the resulting tracks we obtained not only mean
track velocities but also their mean square displacements and diffusion coefficients. With this key information, we were able
to describe particle behavior at high detail and discriminate between particle tracks exhibiting directed movement and
tracks in which particles exhibited free or anomalous diffusion.
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Introduction
Herpesviruses are doublestranded DNA viruses which seem to
have coevolved with their respective hosts [1]. Currently, eight
different human herpesviruses are known. Three can be grouped
into the alpha-subfamily (herpes simplex virus 1, HSV-1; herpes
simplex virus 2, HSV-2; varicella zoster virus, VZV), three into the
beta-subfamily (human cytomegalovirus, HCMV; human herpes
virus 6, HHV-6; human herpes virus 7, HHV-7) and two into the
gamma-subfamily (Epstein-Barr virus, EBV; Karposi-sarcoma
associated virus, KSHV). Despite clinical importance of all human
herpesviruses, most pioneering basic research is done studying
alpha-herpesviruses. It is, however, not clear to what extend results
obtained in one subfamily can be assigned to the other
herpesviruses as comparative studies of the herpesvirus lytic life
cycle are only possible since the introduction of reverse genetics
into all subfamilies [2,3,4,5].
One of the less understood aspects of viral morphogenesis are
the dynamics of viral particle transport. These dynamic events are
studied best by fluorescently labeled virus particles in combination
with live cell fluorescence microscopy. In recent years, recombi-
nant viruses expressing fusions of structural proteins to fluorescent
proteins widely extended our understanding of the dynamic
processes involved in the morphogenesis of a large number of
different viruses [6,7,8,9,10,11,12,13,14,15,16].
The reported approaches concerning herpesviruses can be
roughly divided into three groups. The first approach is the
labeling of a glycoprotein. This allows the tracking of the first steps
of infection from attachment to fusion with host membranes, or
from envelopment to release [17,18]. The second approach is the
utilization of a tegument protein as fusion partner [15,19,20].
Depending on the protein used, this approach allows the tracing of
events after fusion and before envelopment and even in the host
nucleus after attachment of the fusion product to the capsid. The
last approach utilizes a capsid protein [7,21,22]. Only this
approach allows the tracing of most steps of viral morphogenesis
except the ones that solely concern the processing of viral DNA.
Though, a combination of these approaches [5,23,24,25,26] can
be useful to discern morphogenesis steps, e.g. enveloped from non-
enveloped capsids. A capsid-tagged recombinant virus is therefore
most desirable as it allows the tracing of almost all morphogenesis
steps. Until now however, only alpha-herpesviruses like HSV-1,
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pseudorabies virus (PRV) and equine herpes virus type 1 (EHV-1)
[7,22,27,28,29,30] could be engineered to express fluorescent
capsids. In contrast, all attempts to fuse fluorescent proteins to
beta- or gamma-herpesviruses capsid proteins failed so far
[31,32,33].
We therefore aimed to establish new recombinant beta-
herpesviruses expressing labeled capsids by fusing a fluorescent
protein (FP) to a capsid protein. This is however, not an easy task.
Most herpesvirus capsid proteins undergo numerous and highly
ordered interactions with themselves or other proteins to build the
capsid [32]. The pure bulk of several copies of FPs that are needed
to deliver a bright fluorescent signal induces sterical problems and
may render the recombinant viruses non-viable. As first described
by Desai et al. [7] the small capsid protein (SCP) of some alpha-
herpesviruses like HSV-1, PRV [22] VZV [21] and EHV [27]
seem to tolerate an aminoterminal fusion to FPs. This capsid
protein is exceptionally suitable as a fusion partner as it is located
at the outermost of the core-capsid structure, which apparently
gives sufficient steric freedom to accept a fusion to bulky
fluorescent proteins. Moreover, it is a very abundant protein with
900 copies per capsid (6 copies per hexon), which results in a
sufficiently bright fluorescent signal if fused to a fluorescent
protein.
Yet, the tagging of the SCP in HSV-1 resulted in a moderate
growth defect with titers reduced to about 50% compared to wild
type virus. Moreover, the extent of attenuation was indistinguish-
able from a SCP null mutant [5] arguing for the notion that GFP-
tagging of some SCPs rendered them biologically inactive. This is
further supported by another study on PRV showing that the
aminoterminal fusion with GFP renders the fusion product
biologically non-functional [34]. It emerges therefore, that the
tagging of alpha-herpesvirus SCPs is apparently only possible
because they are not essential for virus replication.
In contrast to alpha-herpesviruses the SCPs of beta- as well as
gamma-herpesviruses are essential and all reported attempts to
fuse a fluorescent protein to SCPs of these subfamilies resulted in
non-viable or even dominant negative mutants [31,32,33,35].
Here, we report on the first successful construction of
fluorescent, capsid-tagged murine cytomegaloviruses (MCMV).
These viable viruses carried ectopic insertions of SCP-FP fusions
leaving the wild type (WT) locus of the respective SCP gene
untouched. The resulting recombinant viruses were viable and
exhibited bright fluorescence signals. We used these recombinant
viruses to study capsid transport both during virus entry and egress
by single particle tracking. We could show that intracellular
transport of MCMV-particles is mostly directed and dependent of
microtubules.
Materials and Methods
Cells and Viruses
BALB/c murine embryonic fibroblasts (MEFs), M2-10B4 bone
marrow stromal cells (ATCC CRL-1972), and NIH-3T3 fibro-
blasts (ATCC CRL-1658) were prepared and treated as described
previously [36]. All MCMVs used in this study are based on the
pSM3fr-Dm1-16-FRT bacterial artificial chromosome (BAC) [37].
The corresponding virus designated MCMV-Dm1-16-FRT, lack-
ing the leftmost 16 genes which encode for viral immunoevasins
[38], is designated WT throughout this work because its
replication properties were extensively studied recently and was
found to be indistinguishable from the wild type virus in tissue
culture [37]. All viruses reported in this study were reconstituted
from their respective BACs by nucleofection of NIH/3T3 cells.
Nucleofection was done using an Amaxa 96-Well Shuttle system
(Lonza) according to the manufacturers’ instructions for NIH-3T3
cells. In brief, 56105 cells were nucleofected with 400 ng purified
BAC-DNA and seeded together with 1.56105 non-transfected
cells into one well of a 24 well plate. 3 days after nucleofection, the
cell layer was checked for plaques and split 1:4. Usually, six days
after nucleofection, full CPE could be observed. Cultures were
harvested and samples were frozen as passage zero. Afterwards,
virus inoculi were scaled up on M2-10B4 cells as described
previously [36]. Virus titers were quantified on MEFs by a
standard plaque assay [39].
Analysis of Viral Growth in vitro
MEFs were infected with the viruses to be analyzed in duplicate
at a multiplicity of infection (MOI) of 0.1 plaque forming unit
(PFU) per cell at 37oC. The inoculi were removed after 1 h, then
the cultures were washed three times with Dulbeccos phosphate-
buffered saline (DPBS), normal medium was added and the
incubation was continued. Supernatants of infected cells were
harvested daily on days 1 to 5 after infection, and the amounts of
the released infectious particles were determined by plaque assay
on MEFs.
To determine plaque sizes, standard plaque assays on MEF
were performed in 48-well plates and infected cultures were
overlaid with carboxyl-methylcellulose as described previously
[39]. 5 days post infection the overlay was removed and standard
immunostaining (see below) was performed with a monoclonal
antibody against MCMV ie-1 [58] and matching Alexa-conjugat-
ed secondary antibodies (Invitrogen). Digital images of individual
plaques were obtained by confocal microscopy (see below) and
their pixel size was measured using ImageJs line tool [40] and
converted into mm.
Plasmid Construction
To generate the pOTO-S-GFP-SCP construct we amplified a
sequence with primers SCPPfor and SCPPrev (Table S1) binding
to positions 74153–74173 and 73766–73786 of the MCMV Smith
strain (NCBI Reference Sequence: NC_004065.1), respectively.
The amplicon coded for a proposed m48.2 promoter sequence as
well as the first 34 amino acids (aa) of m48.2. The primer SCPPfor
added an EcoRV site to the 59 end while SCPPrev fused AflII and
SpeI sites as well as a hemagglutinin (HA)-tag coding sequence to
the 39 end. The PCR fragment was cut with EcoRV and AflII and
inserted into the previously described plasmid pO6-IET-gfpSCP
[33] replacing its AflII -SspI fragment.
A further variant of this rescue vector coding for a SCP fusion to
mCherry was generated by amplifying the respective fluorescent
proteins with primers SP-AflII-FP-BsrGI and ASP-AflII-FP-BsrGI
(Table S1) from pmCherry-C1 (Clontech) which added AflII and
BsrGI sites to the respective ends. The PCR-products were cut
with BsrGI and AflII and and inserted into the previously described
plasmid pOTO-S-GFP-SCP, replacing its BsrGI-AflII fragment
resulting in pOTO-S-mCherry-SCP, respectively.
To generate the S-GFP-SCP* mutant, lacking the last 14 C-
terminal codons of the SCP open reading frame (ORF), the
parental vector pOTO-S-GFP-SCP was cut with PvuII and ApaI
thereby removing the coding sequence for the last 17 aa of the C-
terminal region of m48.2. To subsequently restore the missing nine
codons as well as the stop codon, the corresponding region
pOTO-S-GFP-SCP was amplified with primers SP-MCP and
ASP-MCP (Table S1) and inserted by PvuII and ApaI resulting in
pOTO-S-GFP-SCP*.
Recombinational cloning to generate yeast bait and prey vectors
for yeast two hybrid tests was essentially done as described in
Fossum et al. [41]. The plasmids pOTO-S-GFP-SCP or pOTO-S-
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GFP-SCP were used as PCR templates for insert amplification
with primers attB1-S-GFP-SCP-attB2-SP, attB1-S-GFP-SCP-
binding-negative-No-Stop-attB2-ASP and attB1-SCP-S-GFP-
SCP-no-stop-attB2-ASP (Table S1). Resulting PCR products were
subjected to BP-recombination by Gateway-mediated recombina-
tion into pDONR-221 according to the manufacturer’s instruc-
tions (Invitrogen). Subsequently, the coding regions were trans-
ferred to the prey plasmid pGADCg [42], generating the plasmids
pGADCg-S-GFP-SCP and pGADCg-S-GFP-SCP* which code
for a C-terminal fusion to the activation domain (AD).
The integrity of all constructs mentioned above, was confirmed
by analytical digests and DNA sequencing of crucial elements.
Construction of Recombinant MCMV BACs
To insert the expression cassettes into the MCMV BAC we
inserted the above described rescue plasmids into a MCMV-BAC
by the FRT/Flp system. Escherichia coli strain DH10B (Invitro-
gen) containing the pSM3fr-Dm1-16-FRT BAC [37] and the
temperature-sensitive Flp recombinase expression plasmid pCP20
[43] was transformed with various pOTO-constructs carrying the
different SCP fusions and treated as described previously [33].
Correct recombinations were verified by restriction analysis and
sequencing in loco.
Yeast Two Hybrid Analysis
Yeast two-hybrid analysis of interactions between SCP con-
structs and MCP was performed as described in the manufactur-
er’s protocol (BD Biosciences/Clontech). Briefly, the bait plasmid
pGBKT7-MCP [41] was transformed into the yeast strain Y187
while the prey plasmids pGADCg-S-GFP-SCP and pGADCg-S-
GFP-SCP* were transformed into the AH109 strain. Diploid yeast
cells carrying both vectors were generated by mating the strains
and subsequent selection on SDC-Leu-Trp medium. Growth of
diploid cells on SDC-Leu-Trp-His medium was used to assess bait-
pray interaction via the HIS3 reporter. Bait and prey plasmids
without inserts were used as a control.
Density Gradient Purification of Nuclear and Extracellular
MCMV Particles
Gradient purification of extracellular MCMV particles was
either done on self-forming Optiprep (Sigma) gradients or with
10–40% preformed Nycodenz (Axis-Shield). In both cases
supernatants from virus-infected cells were centrifuged at low
speed (5500 g/15 min) to remove cell debris. Afterwards, virions
were concentrated by high-speed centrifugation (23000 g/
210 min) and the resulting virus pellet was carefully resuspended
in VS-buffer (0.05 M Tris, 0.012 M KCL, 0.005 M EDTA,
pH 7.8). Free DNA/RNA was removed by overnight treatment
with 625 U/ml Benzonase (Novagen) at 4uC.
Nycodenz-gradient purification was essentially done as de-
scribed in Doehner et al. [44]. In brief, the resulting suspension
was loaded onto a continuous 10–40% Nycodenz (Axis-Shield)
density gradient prepared on a GradientStation ip (Biocomp) and
separated at 20000 g for 105 min in a Beckman SW28 rotor at
4uC. The resulting bands were visualized and collected on a
GradientStation ip.
Purification of particles in self-forming Optiprep gradients was
done by mixing equal amounts of a 60% Optiprep solution and
resuspended pellet. The mixture was then loaded into centrifuge
tubes and spun at 144.000 g for 16 h. Resulting bands were
visualized over a light source and collected.
Sucrose-gradient purification of nuclear MCMV particles was
done as described by Radtke et al. [45]. After density purification
on a sucrose gradient, bands were collected as described above. All
fractions were analyzed by standard negative-stain electron
microscopy (EM) [46] verifying their integrity and purity.
Analytical Polymerase Chain Reactions (PCRs)
Viral DNA was extracted from Benzonase (Novagen) treated,
gradient purified virions using the DNeasy blood and tissue kit
(Qiagen) according to the manufacturer’s instructions. It was
quantified by real-time PCR using an ABI Prism 7700 sequence
detector (Applied Biosystems). Prior to amplification, purified
DNA was digested with PaeI for 1 h, 37uC followed by heat
inactivation. To determine the ratio of viral genome copy number
to PFU, a quantitative PCR was performed for each sample in
triplicate using MCMV M54 specific primers and probes as
described by Scrivano et al. [47]. Viral DNA copy numbers were
then calculated by comparing the amplification to a standard
curve generated by using a pSM3fr-BAC DNA template. To
normalize for loss of DNA during purification, we determined the
ratio of a defined quantity of pSM3fr-BAC DNA before and after
purification.
Immunoblotting
Viral protein expression was analyzed by infecting a confluent
layer of M2-10B4 cells at a MOI of 1 for 48 h in 6 cm dishes.
Subsequently, cells were washed with DPBS and lysed in total lysis
buffer (62.5 mM Tris, pH 6.8, 2% (v/v) sodium dodecyl sulfate
(SDS), 10% (v/v) glycerol, 6 M urea, 5% (v/v) b-mercaptoethanol,
0.01% (w/v) bromophenol blue, 0.01% (w/vol) phenol red) plus
125 U of Benzonase (Novagen) for 90 min at 4uC. After denatur-
ation at 95uC for 10 min, samples were loaded onto 15% SDS-
polyacrylamide gels and separated by electrophoresis (SDS-
PAGE).
To analyze proteins from purified virions, a volume corre-
sponding to approximately 1.16105 PFU of gradient-purified virus
preparation per lane was diluted in 10 ml of TNE buffer (100 mM
NaCl, 10 mM EDTA, 50 mM Tris-Cl pH 7.5). Virus particles
were precipitated by spinning the samples at 107.000 g for 1 h at 4˚
C. The supernatant was discarded and the pellet resuspended in
reducing 16LDS buffer (Invitrogen), loaded onto 4–15% Bis-Tris
gels (Invitrogen) and separated by SDS-PAGE.
After SDS-PAGE, separated proteins were transferred onto
PVDF membranes in the presence of blotting buffer (25 mM Tris,
192 mM glycine, 20% (v/v)] methanol, pH 8.3). Membranes were
blocked in TBS-T (Tris- buffered saline, 0.05% (v/v) Tween 20)
containing 5% BSA or 5% dry milk for 1 h at room temperature
(RT). To detect the SCP of MCMV, a polyclonal antiserum
directed against SCP was generated by immunizing rabbits with
Ovalbumin (OVA) -coupled peptides corresponding to aa 36–50
and 59–86 m48.2 ORF (Metabion). To detect MCP, a rat
polyclonal antiserum was used [33]. GFP was detected by a
polyclonal rabbit antiserum (Invitrogen). mCherry was detected
with a polyclonal rabbit antiserum generously provided by Vincent
Geli (CNRS Marseille) through Zemer Gitai (Princeton Univer-
sity). The blocked membranes were incubated with the respective
antisera overnight at 4uC and subsequently washed with TBS-T
and incubated with the appropriate horseradish peroxidase-
conjugated (POX) secondary antibody. The HA-tag was detected
with a HA-specific, POX-conjugated monoclonal rat antibody
(Roche) according to the manufacturer instructions. The Western
blot reactions were visualized with SuperSignal West Dura
Extended Duration Substrate (Pierce) using a Fusion luminiscence
reader (Vilber) or autoradiography film and scanned afterwards.
Western blot images were slightly sharpened afterwards with the
unsharp mask tool in Adobe Photoshop.
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Immobilization of Virions on Glass Coverslips
Immobilization of MCMV particles was performed by loading
approximately 16105 PFU of density gradient-purified virus
preparations diluted in 200 ml DBPS onto fibronectin-coated glass
coverslips and incubated for 1 h at 37uC. After binding, virions
were subjected to immunostaining as described below.
Immunostaining for Microscopy
Indirect immunofluorescence analysis was carried out on glass
slides, channel- or 8 well m-slides (Ibidi) by fixing cells or virions
with 4% paraformaldehyde in DPBS (w/v) for 10 min at 37uC.
The fixative solution was replenished twice with DPBS and the
cells were permeabilized for 10 minutes with a solution of 0.1%
Triton X-100 in DPBS. After extensive washing with DPBS, the
cells were blocked using 3% (w/v) BSA in DPBS (blocking
solution) for 1 h at RT. Primary antibodies (anti-MCP rat
polyclonal antiserum [33], anti-GFP rabbit polyclonal antiserum
(Invitrogen), anti-HA-tag rat monoclonal rat antibody (Roche))
were applied in blocking solution and incubated with the cells or
virions at RT for 1 h followed by three DPBS washing steps and
1 h incubation at RT with 1:1000 dilutions of Alexa Fluor-
conjugated, specific secondary antibodies (Invitrogen) in blocking
solution. After a final extensive washing step with DPBS, the
preparations were imaged directly or mounted on glass slides with
Prolong Gold (Invitrogen).
Quantification of Particle Fluorescence Intensity
Distributions
About 16104 PFU of gradient purified virus preparations
diluted in 400 ml DPBS were bound on Poly-Lysin coated glass-
bottom dishes (MatTek) for 1 h at 4uC in the dark. Afterwards
dishes were rinsed once with DPBS and directly imaged on a
Nikon epifluorescence microscope equipped with a 606NA 1.4
objective. Pictures were recorded in 16 bit mode with an EMCCD
camera (Andor iXon 3) and exposure times as well as the EM gain
were adjusted to maximize the recorded dynamic range.
Image analysis was carried out in Matlab 2011b using a custom-
designed software package. The routines loaded each saved image,
removed a slowly-varying background, located the brightest
objects (those greater than 2.5 times the standard deviation of
the background) in each image, extracted a region of interest
about each candidate object, then fitted each candidate to a 2D
Gaussian profile. Candidate source locations were discriminated
from spurious events not consistent with a 2D model of the point
spread function by selectively cutting on the goodness of fit (chi
square) and the width of the fit. The remaining data informed
about the fluorescence distributions of the source population. After
initial isolation and selection, remaining particles were used to
determine the fluorescence distribution of the population by
integrating the best fit Gaussian model over the region of interest
for each particle.
Fluorescence Microscopy
Confocal laser scanning microscopy was performed with either
a Zeiss LSM510 Meta system, a LSM710 system or an Olympus
FV1000 system equipped with high numerical aperture oil
immersion objectives. GFP was excited with a 488 nm laser line.
mCherry was excited with a 543 nm or 561 nm laser line. Protein
fluorescence emission was detected using corresponding filter sets
of the microscopes. Alexa Fluor-Dyes were detected corresponding
to the manufacturers’ instructions. Pinhole diameters were
adjusted to a width corresponding to an optical slice thickness of
1 mm for all channels. Pixel sizes were chosen based on the
Nyquist criteria and varied around 110 nm/Pixel in case of a 63x,
NA 1.4 objective. In general, imaging conditions were chosen
which resulted in an optimal compromise between light exposure
and detector noise and were kept constant in between acquisitions
of the same experiment. Live-cell imaging was performed with
cells growing in m-slides (Ibidi) or glass-bottom dishes (MatTek).
During acquisition, the cells were incubated in an environmentally
controlled chamber at 37uC with either 5% CO2 or in CO2-
independent medium (Invitrogen). All images were processed
according to the journals guidelines using ImageJ [40] as well as
Photoshop CS4 (Adobe) software. Specially, noise in time-lapse
stacks was reduced by Kalman filtering in ImageJ. Gradial
bleaching was corrected by using the ImageJ Bleach Correction
plugin (written by J. Riedorf). All images were contrast-enhanced
to optimize for printing.
Single Particle Tracking
The single virus particle fluorescence patterns obtained were
fitted by a two-dimensional Gaussian function:
I~A0e
{
(x{x0)
2
2s2 e
{
(y{y0)
2
2s2 ð1Þ
where A0 and s are the amplitude and the width at half-maximum
of the two-dimensional Gaussian curve, and x0 and y0 the
coordinates of the position of the individual virus particles. The
single particle tracking procedure was automated using a custom-
written Labview software (National Instruments) [48].
For each trajectory, a set of values for the square displacement,
r2(t), between two observations separated by the time lag tlag =
n N Dt (where Dt is the time interval between successive frames of
the movies, n = 0, 1, 2, …, N-1 with N being the total number of
points in a trajectory) was computed according to:
r2(t)~(~r(tztlag){~r(t))
2 ð2Þ
The Mean Square Displacements (MSD = ,r2(t). ) were then
plotted for every time lag tlag and the MSD plots were fitted for the
10% first time lags (10 points) assuming three different modes of
possible motion [49]:
Normal diffusion:
MSD~4Dt ð3Þ
Anomalous diffusion:
MSD~4Dta ð4Þ
Directed motion with diffusion:
MSD~4Dtz(vt)2 ð5Þ
where D is the diffusion coefficient, a the anomalous exponent and
v the velocity of the directed transport.
To determine for each single trajectory which mode of motion
described the data best, each MSD plot was fitted by Equations 3,
4 and 5 and the reduced chi-squared of the fits were compared.
The normal diffusion model (Equation 3) was used as long as the
more complex model functions of for anomalous diffusion
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(Equation 4) and directed motion with diffusion (Equation 5) did
not resulted in a at least two-fold decrease of the reduced chi-
squared of the fit. In cases in which this condition was fulfilled, the
mode of motion with the minimum reduced chi-squared was
chosen. Hence, this procedure leads to the clustering of diffusing
particles into three distinct classes representing different modes of
diffusion.
Transmission Electron Microscopy (EM)
NIH 3T3 or M2-10B4 cells were grown on carbon-coated
sapphire discs and infected at a MOI of 0.5 with centrifugal
enhancement at 1600 g/RT for 30 min. After an additional hour,
the inoculum was replaced by normal medium and cells were
incubated for 48 h. Then, cells were fixed by high-pressure
freezing with an HPF 01 instrument (M. Wohlwend GmbH),
freeze-substituted, and plastic embedded as described previously
[50]. Embedded samples were thin-sectioned and viewed on a
Zeiss EM 10 at 80 kV in transmission mode. The phenotype of
infected NIH 3T3 or M2-10B4 cells did not differ. Pictures were
recorded on EM film (MACO), digitalized at 1200 dpi, contrast-
enhanced and sharpened with an unsharp mask according to the
journals guidelines in Photoshop CS4 (Adobe).
Immunoelectron Microscopy
Nuclear capsids were adsorpted onto carbon and Formvar-film
coated 400 mesh copper grids (Stork Veco), the samples were
washed with PBS. After blocking unspecific protein binding sites
with 10 mg/ml BSA in PBS the grids were incubated for 30 min
with rabbit GFP-antiserum (Invitrogen, dilution 1:100), then
washed with PBS followed by a 15 min incubation with protein-A
gold (10 nm; Cell Microscopy Center, Utrecht School of
Medicine, The Netherlands). After washing with PBS and distilled
water, preparations were negatively contrasted using 2% (w/v)
uranyl acetate (Merck), and analyzed with a Tecnai G20 (FEI) at
200 kV. For quantitation images of capsids were randomly taken
at a magnification of 55,000x.
Results
Construction of Recombinant MCMVs Producing
Fluorescent Capsids
Our aim was to study beta-herpesvirus capsid dynamics in living
cells. However, a viable, capsid tagged beta-herpesvirus was not
available to track viral particle movements in living cells.
Therefore, we dissected the published approaches to generate
capsid-tagged fluorescent herpesviruses. Since we wanted to
develop a tool that would allow to trace also emerging virus
particles beginning with the first steps of capsid maturation, we
chose to tag the SCP. Besides SCP, there was no successful
approach reported that utilized a known component of herpesvirus
procapsids. Due to the location of this protein at the outer shell of
the capsid, it might allow bulky protein-tags to be added without
sterically disturbing important protein-protein interactions. The
SCP is essential in beta- and gamma-herpesviruses [31,32,35],
while not essential in HSV, PRV and VZV [21,22,51]. All
published trials concerning beta-herpesviruses were based on the
direct fusion of the fluorescent protein (FP) at or into the very N-
terminus of the SCPs, which resembled the strategy originally
published by Desai et al. [7]. The resulting fusion proteins were
non-functional and in some cases even dominant-negative, thereby
preventing virus reconstitution [31,32,33]. Therefore, we reasoned
that a free N-terminus or a sequence motif at the very N-terminus
of the beta-herpesvirus SCP is essential for its function. This was
further supported by an alignment of amino acid (aa) sequences of
all beta-herpesvirus SCPs currently available in the databases,
which showed some conservation in this region (Fig. 1A). Of most
importance in this context was the discovery that MCMV encodes
for a GS-linker like sequence in its SCP N-terminus (aa 10 to 34).
This linker seems to separate the N-terminus into two distinct
regions (Fig. 1A). We proposed that this linker gives the N-
terminus the flexibility that may be required for its interaction with
proteins on the capsid. A bulky fusion partner like GFP might
hinder these interactions by simple sterical means, or the given
flexibility of this linker sequence may not tolerate the unusual
enlargement in size. Therefore, we decided to duplicate the very
N-terminal region consisting of the first 34 aa and fused it,
separated by an additional linker and a HA-tag, to the N-terminus
of GFP. This construct was then fused to the full length SCP
sequence, which includes a second, WT-copy of the N-terminal
domain (Fig. 1B). As this construct consists of the first third of SCP
(S), the green fluorescent protein (GFP) and the full length SCP,
we named this construct S-GFP-SCP. To enable detection in
different imaging setups, we also replaced the GFP coding
sequence with the open reading frames of mCherry, keeping the
same SCP context. To allow BAC technology-based insertion into
the viral context by a simple Flp-recombinase mediated reaction,
we constructed these fusion genes based on the previously
published pO6-IET-gfpSCP plasmid [33]. The plasmid pOTO-
S-GFP-SCP was inserted ectopically into the pSM3fr-Dm1-16-
FRT BAC. This BAC codes for MCMV-Dm1-16-FRT, a virus in
which the first 16 genes at the left side are deleted and an FRT-site
is inserted. The deletion of these genes provided sufficient cloning
capacity for the insertion of recombinant plasmids. This virus was
extensively characterized and found to be indistinguishable from
the wild type MCMV in tissue culture [37]. Moreover, recombi-
nant MCMVs with similar subterminal deletions have also been
reported to replicate like WT MCMV in vitro [38,52]. As the
coding sequence of the fluorescent protein (FP) in the pOTO-S-
GFP-SCP vector was flanked by SpeI-sites, it allowed the SpeI-
mediated removal of the FP resulting in a fusion construct that was
just tagged with a HA-tag. This construct was used to control for
size dependent effects of the insertion. Fig. 1B generally depicts the
resulting constructs.
Reconstitution of the Recombinant MCMVs
Reconstitution of the pSM3fr-Dm1-16-FRT-pOTO-S-FP-SCP
constructs in NIH-3T3 cells resulted in fluorescent plaques with a
distinct fluorescence pattern, which mainly localized to the nuclei
of infected cells (see Fig. 2A for a representative example of the S-
GFP-SCP expressing recombinant). Plaque morphologies as well
as size were comparable to WT virus plaques (Fig. 2A, C). The
same results were obtained for the other S-FP-SCP and the S-HA-
SCP expressing recombinants (Fig. 2C). To elucidate the growth
kinetics of the recombinant virus, we performed multi-step growth
curves on MEF cells. All S-FP-SCP fusions used in this study as
well as the S-HA-SCP mutant showed growth kinetics comparable
to WT (Fig. 2B).
To compare the infectivity of the S-GFP-SCP virions to that of
WT virions, we first determined the genome to PFU ratio. To this
end, we prepared gradient purified virus stocks of both viruses that
were routinely checked for virion integrity and purity by negative-
stain electron-microscopy (EM). Subsequently, we determined the
infectivity of the preparations by standard plaque assay as well as
genome copies by quantitative PCR. The measured genome
copies should equal the amount of DNA packaged into virus
particles, as the virus stocks were treated with the DNA-degrading
enzyme Benzonase during the purification process. Average values
from two independent gradient purifications with simultaneous
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quantification of genome copies in triplicate by real time PCR, as
well as plaque assays to determine the amount of PFU were
compared and the resulting ratios suggested that the S-GFP-SCP
expressing recombinant virus particles and WT particles show
similar infectivity (23 vs. 25 genomes/PFU, respectively, see
Figure 1. Construction of SCP fusion proteins. (A) Alignment of beta-herpesvirus SCP sequences with T-Coffee [62]. A naturally occurring glycin-
serin-linker like sequence separates the N-terminus in MCMV. (B) Detailed representation of the S-GFP-SCP fusion protein as well as the basic genetic
layout of the used mutant viruses carrying a fluorescent protein (FP) and a hemagglutinin tag (HA). GFP or mCherry were used as FPs. The FP could be
removed by a simple SpeI-mediated digest resulting in a construct encoding for just a HA-tagged SCP. N marks the duplicated N-terminal region of
SCP. The plasmids carrying the fusion constructs were inserted into the MCMV BAC by Flp-mediated recombination.
doi:10.1371/journal.pone.0040585.g001
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Fig. 2D). From these data we concluded that our new approach
did not detectably affect viability of the recombinant MCMV.
Characterization of FP-tagged MCMV Particles
Next, we analyzed whether the recombinant S-GFP-SCP virus
produces GFP-tagged virions. To this end, gradient-purified
virions were immobilized on fibronectin-coated cover-slips and
indirect immunofluorescence analysis (IF) was performed with an
antiserum against the major capsid protein MCP [33] as well as
with an antiserum directed against GFP (Fig. 3A). We then
recorded the corresponding fluorescence signals and counted
particle numbers in representative areas with the ImageJ plugin
‘‘Analyze Particles’’. Colocalization was determined with the
‘‘Colocalization’’ command and subsequent counting of coloca-
lized particles. We counted 2653 MCP-positive particles altogeth-
er. 91.46%+/23.88% of them colocalized with an antiserum
directed against GFP, indicating that a high amount of particles
incorporated detectable amounts of S-GFP-SCP. 83.42%+/
23.64% of all MCP-positive particles could also be detected by
their endogenous GFP fluorescence on a low-end confocal
microscope.
Next, we wanted to elucidate if the use of different FPs to tag the
MCMV SCP resulted in differing fluorescence intensity distribu-
tions as described recently for PRV mutants carrying either EGFP
or mCherry tagged SCP [30]. To this end we immobilized either
gradient purified EGFP or mCherry-tagged virions on Poly-L-
Lysine coated cover-glass dishes and recorded particle fluorescence
directly without fixation with a high dynamic range, 16 bit
EMCCD camera. For the mCherry labeled virions, 8120
candidate events were initially isolated of which 5675 (,70%)
were used to determine the fluorescence distribution. For the GFP
labeled virions, 2746 candidate events were initially isolated of
which 2170 (,79%) were used to determine the fluorescence
distribution. The fluorescence brightness of each event was
determined by integrating the best fit Gaussian model over the
region of interest (Fig. 3B).
To compare the intensity histograms, we determined the full
width at half maximum (FWHM) of both viruses, which is a
dimensionless description of the extent of the distribution. The
FWHM for S-mCherry-SCP was about 0.9*105, while the FWHM
for S-GFP-SCP was about 0.5*105, indicating that the virus
populations produced by MCMV S-GFP-SCP and MCMV S-
mCherry-SCP carry comparable minimal and maximal amounts
of fluorescent SCP protein. Interestingly, both distributions were
consistent with multimer Gaussian distributions which was
especially visible in the GFP data. It is well possible that the
suggested multimers representing higher intensities are due to
particle multimers forming during the preparation steps or due to
virus particles having multiple capsids as we regularly observed in
T-EM of infected cells (data not shown).
Next, we used Western blot analysis to visualize GFP or
mCherry labeled SCP in gradient-purified virus preparations
(Fig. 3C). We used three antisera, one specific for SCP, the others
for either GFP or mCherry. We could detect WT SCP in the
parental as well as in the GFP and mCherry tagged virus at
approximately 17 kD which is a more than its calculated size of
about 10 kD (Fig. 3C) which might reflect posttranslational
modification. Also, by using the GFP reactive serum, we found
two S-GFP-SCP and S-mCherry-SCP specific bands each running
between approximately 40 and 50 kD. The upper GFP specific
band was however, much weaker than the mCherry specific band.
Both bands could be also detected by an antiserum reactive to
SCP indicating that these two bands correspond to S-FP-SCP
derivatives. These data indicated that the fusion protein is
incorporated into virus particles. However, the upper GFP and
mCherry specific bands were running about 8 kD higher than
expected for the S-GFP-SCP or S-mCherry-SCP constructs which
might reflect posttranslational modification as seen for WT SCP
while the lower bands reflect the non-modified form. Moreover,
the ratio between them was different when GFP and mCherry
tagged virus were used, possibly reflecting differences in the
amount of posttranslational processing.
S-GFP-SCP Interacts with MCP and is Incorporated into
Viral Capsids in an MCP Dependent Manner
We could show that purified virus particles are fluorescent and
that this fluorescence co-localizes with an anti-MCP staining.
However, this assay is not sufficient to distinguish between a
specific incorporation of the S-GFP-SCP into the capsid and the
unspecific incorporation of the fusion protein into virions via the
tegument due to its high abundance late in infection. Therefore,
we asked whether the S-GFP-SCP fusion protein could specifically
engage with the capsid or a capsid constituent.
As the bulk of tegument is recruited onto capsids in the
cytoplasm, we purified nuclear capsids from S-GFP-SCP infected
cells to test if S-GFP-SCP binds to capsids. We then performed
immunoelectron microscopy with a GFP-specific antiserum on
these capsids and compared the corresponding gold-bead density
with WT nuclear capsids (Fig. 3D). We could detect a mean of
approximately 15 gold beads on S-GFP-SCP nuclear capsids
whereas gold labeling WT nuclear capsids was not significantly
higher than the background frequency arguing for a specific
incorporation of S-GFP-SCP into capsids (Fig. 3D).
To further our notion, we decided to ask if S-GFP-SCP
specifically interacts with a capsid constituent. To this end we used
a genetic approach. It has been shown that HCMV SCP and
MCP interact via a short C-terminal peptide of the SCP [53]. We
therefore checked first, whether this was also true for the MCMV
homologues used in our study. To this end, we deleted the
corresponding peptide in the S-GFP-SCP fusion protein and tested
this mutant (S-GFP-SCP*) as well as the parental S-GFP-SCP in a
yeast-two-hybrid (Y2H) setup against MCP. As shown in Fig. S1,
the S-GFP-SCP fusion protein interacted with MCP while the S-
GFP-SCP* mutant lacking the proposed MCP-binding region did
not.
Knowing that S-GFP-SCP interacts with MCMV MCP via its
MCP-binding motif, we next wanted to know if the S-GFP-SCP*
could be non-specifically incorporated into nuclear capsids. We
therefore generated a MCMV mutant ectopically expressing the
above described S-GFP-SCP* mutant, which is unable to bind to
MCP and is therefore not enriched in the nuclei of infected cells
(see also Fig. S2). By purifying nuclear capsids of this mutant and
Figure 2. Mutants carrying tagged SCP are viable. (A) WT (WT) as well as mutant viruses coding for either HA- (S-HA-SCP) or HA-GFP-tagged wt
SCP (S-GFP-SCP) were titrated on MEF cells. 4 days post infection (dpi) cells were fixed with PFA and processed for immunofluorescence against the
HA-epitope. The scale bars represent 100 mm. (B) Multistep growth curve of mutant viruses used in this study in comparison to WT virus. C)
Comparison of plaque diameters of simultaneously titrated WT, HA-, GFP-, and mCherry-tagged virus 4 dpi on MEF cells. (D) Genome to PFU ratio of
GFP-tagged and WT virus. The ratio between genome content and titer for two independently prepared and purified virus stocks per virus was
determined by titration and quantitative PCR in triplicates.
doi:10.1371/journal.pone.0040585.g002
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Figure 3. GFP-tagged SCP is incorporated specifically into virus particles. (A) Gradient purified virus particles were immobilized on
fibronectin-coated cover-slips, fixed and processed for immunofluorescence. A MCP specific polyclonal serum was used as indicator of virus capsids
and a GFP specific polyclonal antiserum was used to compare MCP and GFP specific signals. Direct GFP fluorescence was detected by excitation with
488 nm laser light and appropriate emission filters. Inserts depict 2x magnifications. Scale bars represent 10 mm and 2.5 mm in inserts. (B)
Quantification of particle fluorescence intensity distributions. Gradient purified S-GFP-SCP or S-mCherry-SCP virus preparations were bound on Poly-
Lysin coated glass-bottom dishes and fluorescent spots were recorded in 16 bit mode. Exposure times as well as the EM gain were adjusted to
maximize the recorded dynamic range. The graph depicts the integrated fluorescence distributions for S-GFP-SCP (black) and S-mCherry-SCP (red). (C)
Immunoblot of gradient-purified virus particles. Approximately 1*105 PFU per lane of wt, (WT), S-GFP-SCP (S-GFP-SCP), S-mCherry-SCP (S-mCherry-
SCP) or S-GFP-SCP* (S-GFP-SCP*) were spun down and lysed. Proteins were separated by SDS-PAGE, blotted and immunodetected with polyconal
sera against SCP, GFP and mCherry. (D) Immunoelectron microscopy of purified nuclear capsids. Nuclear capsids were purified from wt (WT), S-GFP-
SCP (S-GFP-SCP) or S-GFP-SCP* (S-GFP-SCP*) infected cells and immuno gold labeled with an antibody against GFP followed by protein A coupled to
Imaging CMV in Live Cells
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e40585
using them in immune-EM probing for GFP, we were able to
control the interaction between the S-GFP-SCP and the MCP in
the virus context. As shown in Figure 3D and 3E, gold-bead
labeling of S-GFP-SCP* capsids was indistinguishable from what
was seen on the WT particles clearly arguing that S-GFP-SCP*
was not incorporated into nuclear capsids. Moreover, we also
could not detect a GFP specific signal in a Western blot of gradient
purified S-GFP-SCP* virions (Fig. 3C), showing that the S-GFP-
SCP* was also not incorporated non-specifically into virions, e.g.
the tegument layer. Taken together, our results indicated that S-
FP-SCP fusion proteins interact with capsids and that this
interaction is specific and MCP mediated.
S-GFP-SCP and S-HA-SCP Labeled Virus Mutants are
Genetically Stable
Viral genomes carrying unfavorable mutations are facing
negative evolutionary pressure. The occurrence of adaptive
genetic changes in a mutant locus is consequently a sign of
reduced viral fitness of a given mutant. To address the genetic
stability and to assess the fitness of our constructs, we passaged the
S-GFP-SCP carrying virus 5 as well as 10 times on M2-10B4 cells.
As controls, we used WT virus and S-HA-SCP expressing virus.
We reasoned that the latter serves as a good control for insertion-
size dependent effects due to the very small size of the HA-tag
compared to GFP.
First, we wanted to know how our fusion product was expressed
and which changes in protein expression occurred after extended
passages. We therefore infected M2-10B4 cells with passages 0, 5,
and 10 of the above mentioned viruses, lysed the cells 48 hpi and
performed immunoblots specific for GFP, SCP and HA. As shown
in Fig. 4, we could detect a SCP specific signal in all MCMV
infected samples (band g in Fig. 4). We could also detect a S-HA-
SCP specific band (band f) at approximately 22 kD instead of its
predicted 12 kD with both the SCP and the HA tag specific
antisera, again reflecting possible posttranslational modification. In
lanes corresponding to S-GFP-SCP infected cells, we could define
three bands (bands a,b,c) that stained specific for SCP, GFP and
the HA-tag. The two smaller ones (bands b and c), running near
the 46 kD marker band were reminiscent of the ones found in
purified virions (Fig. 3C) while a slower migrating band running
beneath 58 kD (band a) marker was not detected in virions.
Moreover, we could detect two more bands (bands d and e)
beneath 46 kD which were stained positive only by the anti-GFP
antiserum. These bands might reflect SCP-FP sub-populations
which represent protein degradation intermediates and/or post-
translational modifications which are present in the infected cells
but not (efficiently) incorporated into the virions. However, no
major changes in protein expression levels nor in the expressed
protein pattern could be detected upon infection with either
passage 0, 5 or passage 10 of any of the recombinant virus tested.
Therefore, these data indicated that the protein expression levels
of the S-HA-SCP- or S-GFP-SCP-viruses were stable for extended
periods.
To further test the genetic stability of the ectopic SCP locus, we
amplified the corresponding sequences by PCR from supernatants
of cells infected with either passage 0, 5 or 10 of S-HA-SCP or S-
GFP-SCP expressing viruses. The resulting PCR products were
gel-purified, sequenced and checked for sequence alterations.
Again, no alteration could be detected in either of the samples,
arguing for extended genetic stability of both the S-HA-SCP and
the S-GFP-SCP loci (data not shown).
Normal Morphogenesis of S-FP-SCP Tagged
Recombinant MCMV
To analyze whether virus morphogenesis is affected due to the
expression of the S-GFP-SCP fusion protein, cells were infected
with S-GFP-SCP virus and processed for transmission EM 48 h
post infection. As depicted in Fig. 5, all major steps of virus
morphogenesis e.g. capsid assembly, capsid packaging, primary
envelopment in the nucleus as well as secondary envelopment
appeared to be indistinguishable from WT virus in respect to
phenotypic appearance and overall frequency. However, in some
nuclei of S-GFP-SCP infected cells, semi-crystalline structures
could be detected (data not shown). These structures mostly
consisted of non-filled capsids similar to what was observed
previously for a HSV VP26-mRFP virus [23] but also during WT
HSV infection [54]. These data demonstrated that the major
intracellular steps of the viral life cycle appeared to be normal in
the fluorescently tagged MCMV recombinant virus.
Next, we analyzed whether fluorescent virus particles spread
from cell to cell in tissue culture. NIH-3T3 cells were seeded on
cover slips in 24 well plates and infected with a low MOI (100 PFU
per 50000 cells). To prevent virus spread via the supernatant, we
overlaid the infected cells with carboxy-methyl-cellulose as
described for standard plaque assay [39]. Four days after infection,
the overlay medium was removed, plaques were fixed and IF was
performed. MCP was detected by a specific polyclonal antiserum
and compared to S-GFP-SCP fluorescence. In addition, TO-
PRO-3 was used to stain cell nuclei. As shown in Fig. 6, cells at the
center of a plaque exhibited abundant MCP stain and S-GFP-SCP
fluorescence (yellow) inside nuclei, indicating a late infection stage.
Cells at the edge of the plaque (Fig. 6 insert 1), however, did not
show any MCP or S-GFP-SCP signal in their nuclei, indicating
that these cells did not started de novo synthesis of MCP and the
S-GFP-SCP fusion protein. Yet, in some of these cells, we could
detect fluorescent particles next to the cell’s nucleus, adjacent to
the nuclear rim (Fig. 6 insert 2). These particles were positive for
both GFP fluorescence and MCP. Therefore, we concluded that
these particles were most likely virus particles that were
transported to the nucleus of freshly infected cells. This finding
suggests that labeled virions were correctly transmitted from
infected to non-infected cells.
Quantification of Cytoplasmic Movement Paths in
Herpesvirus Egress
After verifying the WT virus properties of the S-GFP-SCP
mutant, we aimed to use this new virus to track MCMV-infection.
As tracking approaches are most easily established on virus entry
scenarios at cell protrusions (due to good signal to noise ratios and
planar environments) we first concentrated our work on cell
protrusions (Fig. S3, Video S1 and data not shown).
After establishing a tracking workflow, we next wanted to know
whether it was possible the quantify the intracellular movements of
newly produced virus particles. In contrast to viral entry [55], this
can only be solved with a genetically encoded fluorescent tag. For
the following experiments, we used the mCherry-labeled MCMV
variant named S-mCherry-SCP. Around 20 h post infection, the
first fluorescent signals emerged in nuclei of MEFs with detection
10 nm gold. The scale bar indicates 50 nm. (E) Quantification of gold-labeling intensity. The amount of gold beads per capsid was counted for at least
20 views containing at least 20 capsids per condition as shown in (D). The mean as well as the standard deviation are depicted.
doi:10.1371/journal.pone.0040585.g003
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parameters suitable for live-imaging (data not shown). Around
24 hpi, fluorescent spots of varying intensity could be followed in
the cytoplasm. These spots most likely represented both, non-
enveloped as well as enveloped viral particles, inside of vesicles.
For alpha-herpesviruses directed cytoplasmic transport of viral
capsids was described to be microtubule-dependent [56]. We
therefore assumed that this was also true for the beta-herpesvirus
MCMV. To test whether the S-mCherry-SCP virus is suitable to
quantify intracellular particle transport, we used this finding as a
touchstone. We infected MEF cells at a MOI of 0.5 with MCMV
Figure 4. Viruses carrying labeled SCP mutants are genetically stable. Immunoblot of M2-10B4 cells infected with either wt, S-HA-SCP, or S-
GFP-SCP virus derived from passages 0, 5 or 10 after reconstitution. Cells were infected at a MOI of 1, and harvested 48 hpi by lysis in total lysis buffer.
Proteins were separated by SDS-PAGE, blotted and immunoprobed for GFP, SCP, HA and MCP as well as beta-Tubulin as loading controls. Lower case
letters indicate discussed protein bands.
doi:10.1371/journal.pone.0040585.g004
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encoding the S-mCherry-SCP fusion protein and dissolved the
microtubule network in control cells 23 hpi by the addition of
5 mg/ml Nocodazole for 1 h and subsequently imaged cytoplasmic
fluorescent signals. An antibody stain against beta-Tubulin was
used to control for the effect of Nocodazole on infected cells (data
not shown). The disruption of the microtubule network had a
dramatic effect on the motility of cytoplasmic fluorescent spots. As
shown in Fig. 7 as well as in Videos S2 and S3, cytoplasmic
movements of fluorescent spots basically stopped, arguing for a
microtubule dependent transport of the bulk of viral particles in
the cytoplasm of MCMV infected cells.
To quantify these cytoplasmic effects, we recorded the
periphery of 7 infected mock and 7 Nocodazole treated cells at
5 frames per second and subsequently tracked randomly most
identifiable fluorescent particles (180 particles in mock-treated
cells/163 particles in Nocodazole-treated cells). We then calculat-
ed their MSD curves by determining the mean square displace-
ments (MSD) and plotting them against the lag time. The resulting
curves were clustered into two classes. The first class included all
mobile particles and the second all immobile particles. We
discerned between these two classes by analyzing their MSD
curves and taking the experimental positioning accuracy of the
used tracking algorithm into account. We determined an
experimental positioning error of around 30 nm per axis which
translates into approximately 14.500 nm2 in our MSD plots. All
curves that did not exceed this value were classified as immobile,
because their change in position during acquisition was less than
the experimental localization accuracy of 30 nm per axis. In
contrast, all particles that exceeded this value were classified as
mobile (Fig. 8A, B). According to this quantification, 88.4% of
particles in mock treated cells were mobile. In contrast, 84.6% of
particles in Nocodazole treated cells were immobile. Surprisingly,
15.4% of the particles in Nocodazole treated cells were still mobile
after 1 h incubation with 5 mg/ml Nocodazole (Fig. 8C).
The mode of diffusion was determined by calculating the mean
square displacements (MSD) and plotting them against the lag
time. To analyze the properties of the mobile populations further,
we fitted the corresponding MSD curves in a two-step process
according to three diffusion models. These models were anoma-
lous diffusion (MSD = 4Dta), free diffusion (MSD = 4Dt) and
directed motion with diffusion (MSD = 4Dt+ (vt) 2) (for details see
materials and methods).
79.2% of mobile particle tracks in mock treated cells could be
fitted with the function MSD = 4Dt+(vt)2 compared to 6.2% in
Nocodazole-treated cells, indicating that a small fraction of
particles in Nocodazole-treated cells exhibited directed motion,
hinting to a possibly Nocodazole-resistant transport mode.
Interestingly, Nocodazole treatment did not strongly influence
the amount of particles diffusing freely (fit with MSD = 4Dt) or in
an anomalous fashion (fit with MSD = 4Dta) (Fig. 8C). Together
with the strong increase of immobile particles under Nocodazole
treatment this findings might suggest that viral particles were
either trapped in a very small molecular cage or fixed to some
molecular anchor after Nocodazole treatment.
As we fitted the mobile fraction of particles that exhibited
directed movement with MSD = 4Dt+(vt)2, we could directly
determine the overall mean velocity of a given particle track
without its diffusion component. As shown in Fig. 8D and E, mean
track velocities (over the complete acquisition time of approxi-
mately 20 sec) in mock treated cells had a mean of
0.10160.073 mm/sec. In Nocodazole treated cells however,
particles that exhibited directed movement had a mean, mean
track velocity of only 0.04160.042 mm/sec. This finding indicated
that high mean track velocities were mostly based on a
Figure 5. Ultrastructural assessment of S-GFP-SCP infected cells. NIH-3T3 and M2-10B4 (upper row) or M2-10B4 cells (lower row) were
infected at a MOI of 0.5 and centrifugal enhancement with WT (upper row) or S-GFP-SCP labeled virus (lower row) and incubated for 48 h. Afterwards,
cells were high-pressure frozen, freeze-substituted, plastic-embedded and thin-sectioned. Depicted are representative details of two independent
experiments showing non-enveloped B- and C-capsids in the nucleus (first column), primary envelopment in the nucleus (2nd column), non-
enveloped C-capsids near cellular membranes possibly during secondary envelopment (third column), as well as enveloped capsids in the cytoplasm
(right column). Scale bars indicate 200 nm.
doi:10.1371/journal.pone.0040585.g005
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Nocodazole-sensitive, and therefore most likely, microtubule-
associated transport mode.
The second parameter we could determine was the diffusion
coefficient D. It was calculated for all mobile particles and the
median in mock-treated cells was 1.24?1028 cm2/s while
0.56?1028 cm2/s in Nocodazole-treated cells (Fig. 8F,G). Interest-
ingly, the distribution width of D in mock treated cells was higher
than expected for a monodispersed particle suspension (Fig. 8F). D
is inversely proportional to the hydrodynamic radius of a particle,
as long as all other variables like temperature and the viscosity of
the medium are not changed (D = kT/6pgr). Therefore, the
observed distribution of D could be an indicator for a wider range
of tracked particle diameters.
Discussion
In this study, we report on beta-herpesviruses that are
genetically tagged at their capsid by FPs. These recombinant
viruses express an additional copy of engineered SCP in cis that
carries the FP at an internal position joined via two flexible linkers.
This second FP-tagged SCP gene is expressed under the control of
its own promoter to maintain physiological levels of expression.
This strategy resulted in production of capsids harboring a mixture
of FP-tagged WT SCP. The presence of the WT SCP seems to be
important, as a similar recombinant BAC lacking the endogenous
SCP was not viable (data not shown). This phenomenon that a
WT allele completely compensates a non-functional mutation
present on a separate allele is well known in herpesvirus genetics
and was utilized to map temperature-sensitive mutants in the past
[57]. The herein described case is similar, but they differ in that
the two alleles are in one genome. Why the WT SCP needed is
unclear. One explanation are sterical constraints as the bulky
fluorescent protein might be perhaps too big to fit six times onto a
capsid hexon, while a mixture of unlabeled and labeled SCPs does.
Another explanation is that the labeled variant cannot engage in
essential interactions with neighboring proteins, but as not all
molecules need to engage in this interaction, the unlabeled
proportion of SCP molecules might be sufficient to compensate
this deficit. Yet, the recombinant MCMV carrying S-HA-SCP was
viable even after deletion of the native SCP locus (data not shown)
arguing for tag-size dependent deficiency of the presented S-FP-
SCPs. This size-dependence may allow the tagging of SCPs at the
native locus utilizing for example the recently published smaller
LOV domain-based, new fluorescent tags like iLov [58] using our
design.
The S-GFP-SCP fusion protein was clearly incorporated into
virus particles, which is due to its interaction with MCP. However,
we cannot exclude that the S-FP-SCP fusion proteins lack other
Figure 6. Fluorescent virus particles are spread-competent. (A) Confluent M2-10B4 cells were infected with S-GFP-SCP labeled virus on cover-
slips in 24-wells with 100 PFU per well and overlaid with methyl-cellulose. 4 dpi cells were fixed and processed for immunofluorescence. MCP-specific
antiserum was used to detect virus producing cells as well as single virus particles while GFP fluorescence was visualized directly. Cell nuclei were
counterstained with TO-PRO-3. Inserts depict single virus particles surrounding a cell nucleus (circles) not showing any evidence for being on the late
stage of infection and producing infectious particles. Scale bars indicate 20 mm in the upper row and 5 mm in the lower row.
doi:10.1371/journal.pone.0040585.g006
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binding functions that have to be substituted by endogenous SCP.
Therefore, although our mutant fusion protein is not a substitute
for WT SCP, it is not inhibitory as shown virus growth kinetics,
plaque diameter and genome number to PFU ratios. The WT-
virus like properties of the new recombinant FP tagged MCMVs
are an important advance, as a quite similar GFP-SCP fusion
developed earlier in our laboratory showed a strong dominant
negative effect on virus growth when expressed in cis from an
inducible locus [59]. The difference between these two fusions is
essentially the duplication of the first 34 aa that are added to the
N-terminus of the fluorescent protein. These 34 aa might engage
in important interactions or provide additional flexibility that
discerns the S-GFP-SCP fusion from its dominant negative
ancestor gfp-SCP.
Recently, it was shown that PRV mutants carrying a GFP
tagged SCP exhibit a much wider intensity distribution than an
equivalent mutant carrying mRFP instead of GFP. [30]. In the
here-described mutants, the FWHMs were quite similar, with an
about two-fold difference between GFP and mCherry (an mRFP
variant). In our case however, the mCherry-tagged mutant showed
the higher value compared to the GFP-tagged variant. Interest-
ingly, we found evidence for a multimer Gaussian distribution.
This might be due to virus particles having multiple capsids as we
regularly observed in T-EM of infected cells (data not shown) or
due to aggregation of particles during the purification procedure
which is necessary to remove cellular debris.
We next tested for phenotypic changes in the ultrastructure of
infected cells and could not find obvious morphological differences
except for some cells in a late stage of infection that showed
parachrystalline arrays of what seemed to be B-capsids. This
phenomenon is also described for HSV-1 carrying an mRFP-
tagged SCP as well as for WT HSV-1 infection [23,54].
The quantification of capsid labeling intensity as well as the
proportion of labeled particles revealed that most particles are
labeled to an extent that permitted particle tracking.
We also tried to tag the SCP of HCMV by the same strategy
and this resulted in a strongly attenuated recombinant virus. These
data indicated that the procedure was merely correct but that fine-
tuning of the labeling approach is necessary for each herpesvirus
species. Probably, the size of the inserted tag is crucial. Also, there
might be a difference in oversize tolerance in the different
herpesvirus species.
Next, we tested purified virus preparations of MCMV S-GFP-
SCP in an entry assay and could detect particle attachment to cell
protrusions and trafficking along those. We were able to establish a
tracking workflow with few particles that resulted in a very
accurate localization of single virus particles (45619 nm) (see Fig.
S3). Tracking extracellular viral particles provides an environment
with low background and low particle densities and is ideal to
establish a tracking workflow. But viral entry in general can be, at
least with non-enveloped viruses, also followed with chemically
labeled virions [55]. The huge advantage of a virus genetically
encoding fluorescent markers is the possibility to follow the fate of
newly produced intracellular viral particles. Particle movement in
the cytoplasm during virus egress, however, happens in an
environment characterized by high background noise, high
particle counts and a reduced cell cross section due to virus
induced cell rounding. We tracked particles shortly after they
appeared first in the cytoplasm and tracked their motility. As
negative-control we used infected cells treated with the microtu-
bule depolymerizing drug Nocodazole. By using a sophisticated
Figure 7. Nocodazole blocks MCMV fluorescent particle mobility. MEF cells were infected with S-mCherry-SCP for 23 h and treated with
5 mg/ml Noccodazole for 1 h or not. S-mCherry-SCP-emission in live cells recorded under environmentally controlled conditions with 5 frames per
second. Fluorescence intensity is coded in false-colors from dark blue to yellow. Three frames from a time-lapse stack each recorded 6 seconds (30
frames) apart are shown for a non-treated (upper row) and Nocodazole treated cell (lower row). Lines indicate the nucleus (Nuc.) as well as the
cytoplasm (Cyt.). Circles indicate the position of a fluorescent particle. The right picture depicts all quantified tracks with ellipses marking the tracks
from the particles highlighted on the left.
doi:10.1371/journal.pone.0040585.g007
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fitting approach, we could cluster the obtained particle tracks into
four classes representing immobile particles and mobile particles
exhibiting either anomalous diffusion, free diffusion or directed
motion. We found that Nocodazole treatment reduced the fraction
of mobile particles drastically from approximately 88% to 15%.
This effect was mainly due to the reduction of particles exhibiting
directed motion (79% to 6%), while the proportion of particles
exhibiting free or anomalous diffusion did not change strongly.
This was anticipated, as it was shown before that viral cytoplasmic
transport is mainly microtubule-mediated. However it was
surprising, that the dissociation of microtubules by Nocodazole
did not increase the proportion of free or anomalous diffusing
particles much (4.4% to 6.8% and 5.2% to 2.5% respectively).
This finding might indicate that particles are still bound to
microtubule fragments after Nocodazole treatment as the tracking
data indicated a very large proportion of particles that did not
move more than the localization precision of 30 nm (classified as
immobile). Yet, other mechanisms for immobilization of capsids,
such as entrapment in a molecular cage or fixation to a molecular
anchor, are also possible.
Remarkably, still around 6% of particle tracks from Nocoda-
zole-treated cells could be fitted according to a directed motion
model. Two explanations seem plausible. First, the remaining
movement upon treatment with Nocodazole may be caused by the
presence of stabilized Nocodazole resistant microtubules, similar to
those which have been described for HSV-1 infections [60].
Alternatively, the observed Nocodazole-resistant movement is
based on actin filaments, a hypothesis that is underlined by the
recent report describing the dependence of HSV-1 virion secretion
on Myosin V [61]. However, to specifically address this question,
future experiments are needed.
Instead of a focused distribution of the diffusion coefficient as
anticipated for a monodisperse solution of particles, we found a
wider distribution of D. Assuming a uniform cytoplasmic viscosity
this finding would translate into a non-uniform distribution of
vesicle sizes used by the virus to transport particles. A simple
explanation for the wider distribution of D could be that it reflects
to the size difference between enveloped and naked capsids. In
addition, we could observe a great difference in vesicle sizes for
virus containing vesicles in transmission EM (Fig. 5 and data not
shown). The sum of these interpretations might translate to the
observed phenotype. Moreover, it demonstrates the power of
single-particle tracking to probe the environment of the measured
particles without the need of extensive co-labeling.
We also calculated mean track velocities from particle tracks
which could be fitted according to a model for directed movement.
Notably, this mean track velocities were much smaller than what is
reported for HCMV [15]. This might have several reasons apart
from intrinsic differences between HCMV and MCMV: First, we
randomly chose particles that were technically possible to track
and did not select for mobile particles. Therefore, our mean step
velocities had to be smaller as more slowly moving particles were
included. In addition, we used a different tracking and calculation
approach. The mean track velocities used here, display the mean
velocity a given particle exhibits over the whole measured track. As
we did not select for fast transport processes during tracking nor
used track segmentation as shown in Fig. S3, our mean track
velocities had to be smaller than velocities from ‘‘hand-picked’’
(sub-)tracks. The approach taken here should be therefore much
better suited to approximate a realistic mean transport velocity
with which cytoplasmic herpes particles are transported over
longer time spans.
Up to now, we did not quantify the cytoplasmic motility of other
similarly tagged viruses. Future studies are aimed to discern
enveloped from non-enveloped particles (e.g. with an additional
glycoprotein-FP fusion) and to study the direction of transport to
produce a more detailed picture of cytoplasmic transport processes
during MCMV egress.
Altogether, we were able to generate the first viable and stable
recombinant beta-herpesvirus that produces fluorescently labeled
capsids. In comparison to the widely used HSV-1 and PRV
capsid-tagged mutants, the here described recombinant did not
show any growth defect in cell culture and exhibited biological
features comparable to their parental WT virus [5,34]. All tested
recombinants produced fluorescent virus capsids with an intensity
sufficient to track single particles over extended periods in live-cell
microscopy. The analysis of intracellular particle transport during
MCMV egress, for the first time with subpixel-spatial- and high
temporal- resolution in the herpesvirus field, enabled us to
characterize the cytoplasmic transport of a beta-herpesvirus with
high detail.
Future studies are entitled to transfer the herein described
approach to label a gamma-herpesvirus which would enable the
comparative study of alpha-, beta- and gamma-herpesvirus capsid
dynamics.
Supporting Information
Figure S1 (in support of Fig. 3) Schematic diagram
summarizing the results from a yeast two-hybrid assay,
probing the interaction between MCP and S-GFP-SCP or
S-GFP-SCP*. The S-GFP-SCP* mutant lacks the last 14 aa at the
C-terminus which are predicted to interact with MCP. As a control,
empty bait and prey plasmids were used (ctrl). White squares
indicate no growth on selective agar and a failure of interaction.
Black squares indicate growth on selective agar and an interaction.
(TIF)
Figure S2 (in support of Fig. 3) MEFs were seeded in 8-
well plastic slides and infected with 100 PFU of virus/
per well expressing ectopically either S-GFP-SCP (top)
or a S-GFP-SCP fusion protein lacking its proposed
MCP-interaction peptide (S-GFP-SCP*, bottom). Cells
were overlaid with methyl-cellulose after infection and fixed and
processed for immunofluorescence 4 dpi. GFP fluorescence was
visualized directly while the cytoplasm and cell nuclei were
counterstained with a high concentration of TO-PRO-3, thereby
staining whole cells but still indicating the cell nuclei. The mutant
lacking its MCP interacting peptide is localized throughout the
cyto- and nucleoplasm. Scale bars indicate 10 mm.
(TIF)
Figure 8. Quantification of particle tracks. (A) 180 particles from mock treated cells and were tracked and their MSDs plotted against the lag
time. Particle tracks were clustered into two classes representing mobile (left diagram) and immobile particles (right diagram) depending on the MSD
trend. (B) 163 tracks from Nocodazole treated cells were clustered the same way as in (A). Mobile particles were further clustered depending on which
mode of diffusion they exhibited according to their fit to three different diffusion models. (C) Distribution of particle mobility classes for mock- as well
as Nocodazole-treated cells depicted in percent. The data is categorized into four classes (immobile, anomalous diffusion, free diffusion, directed
motion). (D) Histogram displaying the distribution of mean track velocities of all particles exhibiting directed motion. (E) The same data as in (D)
summarized in a box plot with median (line) mean (square), 25th to 75th percentile (box) and whiskers (5th to 95th percentile). (F) Histogram showing
the distribution of all measured diffusion coefficients. (G) Box plot of the same data shown in (F).
doi:10.1371/journal.pone.0040585.g008
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Figure S3 (in support of Fig. 7 and 8) Tracing of
extracellular particle trafficking. M2-10B4 cells were seeded
at low density on glass-bottomed culture dishes and infected at a
MOI of 100 with gradient purified and EM-controlled S-GFP-
SCP virus stock. Directly after infection, live imaging with 488 nm
laser excitation as well as differential interference contrast (DIC)
was started in an environmentally controlled chamber. Virus
particles attached to cell protrusions were identified by their
fluorescence and recorded with 1.8 frames per second. (A) The
changing positions of two fluorescent particles on a cell protrusion
are depicted over time (circles). Numbers indicate individual
particles. (B) Tracks of particle 1 and particle 2 (insert). No
positions for the particles 1 and 2 could be obtained where particle
tracks overlapped; therefore each particle track is divided in two
parts (both are black for particle 1, red and black for particle 2).
Manual track separation was done by choosing sub-trajectories in
which the particles clearly exhibit long-distance movements. Each
obtained sub-trajectory was then analyzed individually by
computing their MSDs and fitting the resulting MSDs plots
according to the models stated for Fig. 8. The 19 manually chosen
subtracks in which particles clearly showed long distance
movements are indicated by color overlays. The direction of
movement is indicated by arrows. (C) Histogram displaying the
distribution of measured mean track velocities for all used
subtracks in which particles showed long-distance movements.
(D) Histogram depicting the distribution of measured diffusion
coefficients for the same subtracks as in (C). We determine the
overall mean track velocity (v) and diffusion coefficient (D) from all
subtracks. For the two selected particles the mean track velocity of
the subtracks was 0.1060.05 mm/sec and the mean of D was
5.8763.3 mm2/sec, which indicated a high mobility (D).
(TIF)
Table S1 Summary of primers used in this study.
(PDF)
Video S1 (in support of Fig. 7 and Figure S3) Tracing of
extracellular MCMV trafficking. M2-10B4 cells were seeded
at low density on glass-bottomed culture dishes and infected at a
MOI of 100 with gradient purified S-GFP-SCP virus stock.
Directly after infection fluorescence live cell imaging with 488 nm
laser excitation in parallel with differential interference contrast
(DIC) microscopy was started in an environmentally controlled
chamber. Virus particles attached to cell protrusions were
identified by their fluorescence and recorded with 1.8 frames per
second. The video is an overlay of the DIC and GFP channels.
(AVI)
Video S2 (In support of Fig. 7) Nocodazole blocks
MCMV fluorescent particle mobility. MEF cells were
infected with S-mCherry-SCP for 23 h and treated with 5 mg/
ml Nocodazole for 1 h. Imaging and presentation conditions were
the same as for video S3.
(AVI)
Video S3 (In support of Fig. 7) Mobility of fluorescent
MCMV particles. MEF cells were infected with S-mCherry-
SCP for 24 h. Afterwards S-mCherry-SCP-emission was recorded
in live cells under environmentally controlled conditions with 5
frames per second. Fluorescence intensity is coded in false-colors
from dark blue to yellow.
(AVI)
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